These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6685590)

  • 1. [Effects of prostaglandin El on severe diabetic neuropathy].
    Kamio N; Ishihara H; Kondo T; Kobayashi I
    Horumon To Rinsho; 1983 Sep; 31(9):887-92. PubMed ID: 6685590
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical observation of combined therapeutic effect of prostaglandin E1 and mecobalamin on diabetic peripheral neuropathy].
    Zhu XP; Zhou ZG
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):343-4. PubMed ID: 12536730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prostaglandin E1 on hemodynamics and blood gases in severe left heart failure.
    Jacobs P; Naeije R; Renard M; Melot C; Mols P; Hallemans R
    J Cardiovasc Pharmacol; 1983; 5(1):170-1. PubMed ID: 6186854
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute effect of prostaglandin E1 in severe heart failure--effects on hemodynamics, blood gases and metabolic responses].
    Okano H; Ichikawa T; Nishikawa H; Nakano T; Takezawa H; Morimoto Y; Kodera T; Kanamaru M
    Kokyu To Junkan; 1984 Jul; 32(7):733-40. PubMed ID: 6541803
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
    Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K
    Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic effects of prostaglandin E1 on 59 cases of heart dysfunction].
    Zhang LS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Mar; 13(1):35-7. PubMed ID: 4040007
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical application of prostaglandin on peripheral neuropathy].
    Nakamura Y; Takahashi M
    Nihon Rinsho; 1990 Jun; 48(6):1224-8. PubMed ID: 2384972
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effects of prostaglandin E1 in diabetic patients].
    Taveggia G; Selletti L
    Minerva Cardioangiol; 2003 Jun; 51(3):317-22. PubMed ID: 12867884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy.
    Hoshi K; Mizushima Y; Kiyokawa S; Yanagawa A
    Drugs Exp Clin Res; 1986; 12(8):681-5. PubMed ID: 3757764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on Deng et al. entitled "meta-analysis of methylcobalamin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy".
    Lu E; Meng Y
    Endocrine; 2014 Dec; 47(3):973-4. PubMed ID: 25027297
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of prostaglandin E1 on pulmonary circulation and oxygen delivery in patients with adult respiratory distress syndrome].
    Tokioka H; Kobayashi O; Saeki S; Maeda N; Ohta Y; Kosaka F
    Kokyu To Junkan; 1984 May; 32(5):519-21. PubMed ID: 6540890
    [No Abstract]   [Full Text] [Related]  

  • 12. Beneficial effects of prostaglandin E1 in rapidly progressive glomerulonephritis.
    Niwa T; Maeda K; Asada H; Yamamoto M; Yamada K
    N Engl J Med; 1983 Apr; 308(16):969. PubMed ID: 6682176
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostaglandin E1 in neonates with critical congenital heart disease.
    Dungan WT; Norton JB; Readinger RI; Sotomora RF
    J Ark Med Soc; 1982 Oct; 79(5):167-70. PubMed ID: 6183249
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of prostaglandin E1 in ductus-dependent congenital cardiopathies].
    Marcial MB; Maluf M; Atik E; Vargas H; Baucia JA; Verginelli G
    Arq Bras Cardiol; 1983 Jun; 40(6):383-6. PubMed ID: 6686760
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandin E1 treatment of schizophrenia.
    Kaiya H
    Biol Psychiatry; 1984 Mar; 19(3):457-63. PubMed ID: 6539131
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostaglandin E1 in obstructive peripheral vascular disease.
    Fernandez NA; Rosenberg V; Lee M; Singer A
    Mt Sinai J Med; 1983; 50(3):213-7. PubMed ID: 6604865
    [No Abstract]   [Full Text] [Related]  

  • 17. Bilateral ptosis with ophthalmoplegia in a 72-year-old woman with diabetes.
    Nakai A; Nishida Y; Kondou K; Mokuno T; Oda N; Sawai Y; Mano T; Kotake M; Masunaga R; Yamamoto H
    Diabetes Res; 1994; 26(2):89-92. PubMed ID: 7554729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with prostaglandin E1 in the treatment of arteriosclerosis obliterans. A preliminary report.
    Ambrus JL; Taheri P; Killion D; Donaldson G
    J Med; 1983; 14(1):1-15. PubMed ID: 6577118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effects of prostaglandin E1 on experimentally induced atherosclerosis].
    Wang TL
    Zhonghua Yi Xue Za Zhi; 1985 Jan; 65(1):13-6. PubMed ID: 2983846
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandin E1 therapy for peripheral vascular disease is better than placebo.
    Clin Physiol; 1982 Apr; 2(2):163-5. PubMed ID: 7044658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.